Cover Image
市場調查報告書

美國的人工心臟瓣膜市場預測

United States Prosthetic Heart Valves Market Outlook to 2021

出版商 GlobalData 商品編碼 302397
出版日期 內容資訊 英文 102 Pages
訂單完成後即時交付
價格
Back to Top
美國的人工心臟瓣膜市場預測 United States Prosthetic Heart Valves Market Outlook to 2021
出版日期: 2016年01月18日 內容資訊: 英文 102 Pages
簡介

本報告提供美國的人工心臟瓣膜市場相關資料,提供機械瓣膜,生物學心臟瓣膜,經導管瓣膜等各類別銷售額,銷售數的實際成果及預測,平均價格,企業佔有率,流通佔有率,再彙整主要企業簡介,開發中產品,主要的財務相關交易的最新資訊等等,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 報告的內容
  • 人工心臟瓣膜市場區分
  • 該報告對象市場定義

第3章 美國的人工心臟瓣膜市場

  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第4章 主要企業概要

  • Edwards Lifesciences Corporation
  • Medtronic, Inc.
  • St. Jude Medical, Inc.
  • Sorin S.p.A.

第5章 人工心臟瓣膜市場開發中產品

第6章 財務交易情勢

  • 發行公司債券
  • 聯盟
  • 創業融資

第7章 最近的趨勢

  • 企業通訊
  • 財務發表
  • 政府及公益相關
  • 法律規章
  • 其他重要的動向
  • 產品資訊
  • 策略及產業規劃

第8章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECC1435DB

GlobalData's new report, "United States Prosthetic Heart Valves Market Outlook to 2021", provides key market data on the United States Prosthetic Heart Valves market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Prosthetic Heart Valves market segments - Mechanical Heart Valves, Tissue Heart Valves and Transcatheter Heart Valves.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Prosthetic Heart Valves market.
  • Global corporate-level profiles of key companies operating within the United States Prosthetic Heart Valves market.
  • Key players covered include Edwards Lifesciences Corporation, Medtronic plc, St. Jude Medical, Inc. and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Prosthetic Heart Valves Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Prosthetic Heart Valves Market, United States

  • 3.1. Prosthetic Heart Valves Market, United States, Revenue ($m), 2007-2014
  • 3.2. Prosthetic Heart Valves Market, United States, Revenue ($m), 2014-2021
    • 3.2.1. Mechanical Heart Valves Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.2. Tissue Heart Valves Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.3. Transcatheter Heart Valves Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.4. Mechanical Heart Valves Market, United States, Revenue ($m), by Segment, 2014-2021
    • 3.2.5. Tissue Heart Valves Market, United States, Revenue ($m), by Segment, 2014-2021
    • 3.2.6. Transcatheter Heart Valves Market, United States, Revenue ($m), by Segment, 2014-2021
  • 3.3. Prosthetic Heart Valves Market, United States, Volume (Units), 2007-2014
  • 3.4. Prosthetic Heart Valves Market, United States, Volume (Units), 2014-2021
    • 3.4.1. Mechanical Heart Valves Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.2. Tissue Heart Valves Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.3. Transcatheter Heart Valves Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.4. Mechanical Heart Valves Market, United States, Volume (Units), by Segment, 2014-2021
    • 3.4.5. Tissue Heart Valves Market, United States, Volume (Units), by Segment, 2014-2021
    • 3.4.6. Transcatheter Heart Valves Market, United States, Volume (Units), by Segment, 2014-2021
  • 3.5. Prosthetic Heart Valves Market, United States, Average Price ($), 2007-2021
  • 3.6. Prosthetic Heart Valves Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 3.7. Prosthetic Heart Valves Market, United States, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in United States, Prosthetic Heart Valves Market

  • 4.1. Edwards Lifesciences Corporation
    • 4.1.1. Company Overview
  • 4.2. Medtronic plc
    • 4.2.1. Company Overview
  • 4.3. St. Jude Medical, Inc.
    • 4.3.1. Company Overview
  • 4.4. Sorin S.p.A. (Inactive)
    • 4.4.1. Company Overview

5. Prosthetic Heart Valves Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Acquisition
    • 6.1.1. CryoLife to Acquire On-X Life Technologies for USD130 Million
    • 6.1.2. Abbott Labs Denies Talks to Acquire St. Jude Medical for USD25 Billion
    • 6.1.3. Medtronic Acquires Twelve for up to USD458 Million
    • 6.1.4. Abbott Labs Acquires Remaining Stake in Tendyne for USD250 Million
    • 6.1.5. Medtronic Acquires Aptus Endosystems for USD110 Million
  • 6.2. Venture Financing
    • 6.2.1. Twelve Raises USD35.2 Million in Venture Financing
    • 6.2.2. InterValve Secures USD3 Million from Oxford Finance

7. Recent Developments

  • 7.1. Corporate Communications
    • 7.1.1. Sep 14, 2015: Incoming St. Jude Medical President and CEO Mike Rousseau Announces Executive Leadership Team
    • 7.1.2. Sep 09, 2015: St. Jude Medical Announces Leadership Transition Plan
    • 7.1.3. Aug 05, 2015: St. Jude Medical Appoints David Dvorak to Its Board of Directors
    • 7.1.4. Jul 30, 2015: Edwards Announces Board Change
    • 7.1.5. Jun 25, 2015: Medtronic Names Geoff Martha Executive Vice President and President, Restorative Therapies Group
    • 7.1.6. Feb 10, 2015: Edwards Announces Board Changes
  • 7.2. Financial Announcements
    • 7.2.1. Dec 18, 2015: BRILIQUE (ticagrelor) receives positive European Union CHMP opinion for extended treatment of patients with a history of heart attack
    • 7.2.2. Dec 18, 2015: Sarepta Therapeutics Announces FDA Advisory Committee Meeting to Review Eteplirsen as a Treatment for Duchenne Muscular Dystrophy Amenable to Exon 51. Skipping
    • 7.2.3. Oct 26, 2015: Edwards Lifesciences Reports Third Quarter Results-2015
    • 7.2.4. Sep 30, 2015: MediWound Awarded BARDA Contract Valued Up to $112 Million for Development and Procurement of NexoBrid for the U.S.
    • 7.2.5. Jul 28, 2015: Bio-Rad Announces U.S. FDA Pre-Market Approval for the BioPlex 2200 HIV Ag-Ab assay, a Novel Next Generation HIV Diagnostic Test
    • 7.2.6. Jul 28, 2015: Edwards Lifesciences Reports Second Quarter Results
    • 7.2.7. Jul 22, 2015: St. Jude Medical Reports Second Quarter 2015 Results
    • 7.2.8. Jun 02, 2015: Medtronic Reports Fourth Quarter and Fiscal Year 2015 Financial Results
    • 7.2.9. May 19, 2015: Medtronic Announces Preliminary Fourth Quarter and Fiscal Year 2015 Revenue Results
    • 7.2.10. Apr 23, 2015: Edwards Lifesciences Reports First Quarter Results
    • 7.2.11. Apr 22, 2015: St. Jude Medical Reports First Quarter 2015 Results
    • 7.2.12. Feb 20, 2015: ContraVir Pharmaceuticals Provides Clinical Update on FV-100
    • 7.2.13. Feb 20, 2015: St. Jude Medical Announces Increase in Quarterly Dividend
    • 7.2.14. Feb 03, 2015: Edwards Lifesciences Reports Fourth Quarter And Full Year Results
    • 7.2.15. Jan 28, 2015: St. Jude Medical Reports Fourth Quarter and Full-Year 2014 Results
    • 7.2.16. Jan 14, 2015: St. Jude Medical Announces Preliminary Fourth Quarter Financial Results
    • 7.2.17. Jan 13, 2015: European Medicines Agency Grants Positive Opinion for Orphan Drug Status for Ovarian Cancer Oncolytic Vaccine
  • 7.3. Government and Public Interest
    • 7.3.1. Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean
  • 7.4. Legal And Regulatory
    • 7.4.1. Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury's Notice 2015-79
    • 7.4.2. Oct 05, 2015: Bioprosthetic Aortic Valves: FDA Notification - Reduced Leaflet Motion
    • 7.4.3. Apr 02, 2015: Medtronic To Pay $4.41 Million To Resolve Allegations That It Unlawfully Sold Medical Devices Manufactured Overseas
    • 7.4.4. Feb 06, 2015: Medtronic to Pay $2.8 Million to Resolve False Claims Act Allegations Related to "SubQ Stimulation" Procedures
  • 7.5. Other Significant Developments
    • 7.5.1. Oct 23, 2015: Martha Marsh Appointed To Edwards Lifesciences Board Of Directors
    • 7.5.2. Oct 21, 2015: St. Jude Medical Reports Third Quarter 2015 Results
    • 7.5.3. May 27, 2015: Novocure Announces Commercial Launch of Optune (the NovoTTF-100A System) in Japan
    • 7.5.4. Jan 12, 2015: Medtronic Awards $150,000 Locally in Health Access Grants
  • 7.6. Strategy And Business Planning
    • 7.6.1. Mar 02, 2015: PeaceHealth and OHSU collaborate to enhance heart and vascular surgery services

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Market Modeling and Forecasting
    • 8.1.5. Company Share Analysis
    • 8.1.6. Distribution Share Analysis
  • 8.2. Expert Panel
  • 8.3. GlobalData Consulting
  • 8.4. Contact Us
  • 8.5. Disclaimer

List of Tables

  • Table 1: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 4: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 5: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 6: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 7: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 8: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 9: Prosthetic Heart Valves Market, United States, Volume (Units), Historic, 2007-2014
  • Table 10: Prosthetic Heart Valves Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 11: Mechanical Heart Valves Market, United States, Volume (Units), Historic, 2007-2014
  • Table 12: Tissue Heart Valves Market, United States, Volume (Units), Historic, 2007-2014
  • Table 13: Transcatheter Heart Valves Market, United States, Volume (Units), Historic, 2007-2014
  • Table 14: Mechanical Heart Valves Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 15: Tissue Heart Valves Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 16: Transcatheter Heart Valves Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 17: Prosthetic Heart Valves Market, United States, Average Price ($) Historic, 2007-2014
  • Table 18: Prosthetic Heart Valves Market, United States, Average Price ($), Forecast, 2014-2021
  • Table 19: Prosthetic Heart Valves Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 20: Prosthetic Heart Valves Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 21: Prosthetic Heart Valves Market Pipeline Products
  • Table 22: CryoLife to Acquire On-X Life Technologies for USD130 Million
  • Table 23: Abbott Labs Denies Talks to Acquire St. Jude Medical for USD25 Billion
  • Table 24: Medtronic Acquires Twelve for up to USD458 Million
  • Table 25: Abbott Labs Acquires Remaining Stake in Tendyne for USD250 Million
  • Table 26: Medtronic Acquires Aptus Endosystems for USD110 Million
  • Table 27: Twelve Raises USD35.2 Million in Venture Financing
  • Table 28: InterValve Secures USD3 Million from Oxford Finance
  • Table 29: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

List of Figures

  • Figure 1: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 4: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 5: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 6: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 7: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 8: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 9: Prosthetic Heart Valves Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 10: Prosthetic Heart Valves Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 11: Mechanical Heart Valves Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 12: Tissue Heart Valves Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 13: Transcatheter Heart Valves Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 14: Mechanical Heart Valves Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 15: Tissue Heart Valves Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 16: Transcatheter Heart Valves Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 17: Prosthetic Heart Valves Market, United States, Company Share (%) 2014
  • Figure 18: GlobalData Epidemiology-Based Forecasting Model
  • Figure 19: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 20: Primary Interviews by Participant Type (%)
Back to Top